ILA AGM notes
Positive vibes from the mgmt. Quite confident overall.
Phil Lynch, our incoming chair was present and always good to speak to him.
Jason Carol is quite positive on the company’s prospects. He has been invested since the IPO and continues to buy on market.
The cash injection seems to have given the mgmt the fuel they needed to progress their trials and the new drug acquisition, which also seems to have contributed to their positive outlook.
I inquired if they were speaking to the FDA about the animal rule being available for Gal and David Foster (DF) replied that they couldn’t directly speak to the FDA about it because we don’t own the drug yet but they were speaking to their regulatory advisors.
DF was very kind to me and others present and spent a lot of time speaking to us and trying to get to know us.
Therese were no other questions in the room (only a couple of investors present) or online. I think DF’s presos are well honed and cover most aspects anyway.
These are mostly my opinions and no advice.
(20min delay)